Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Glycine Treatment of Prodromal Symptoms
Brief Summary: This is an open label trial of the NMDA agonist glycine used alone for symptoms that appear to be prodromal for schizophrenia in adolescents and young adults.